In a case that's sending ripples through the medical tech industry, federal prosecutors in Chicago have issued indictment charges against two China-based companies and four individuals in an alleged trade secret conspiracy. The charges stem from an accusation that former employees of Philips Medical Systems, an Illinois-based company specializing in X-ray technology, colluded with these entities to misappropriate proprietary information.
The indictment, as reported by The U.S. Attorney's Office for the Northern District of Illinois, details the involvement of KUNSHAN GUOLI ELECTRONIC TECHNOLOGY CO. LTD. and KUNSHAN YIYUAN MEDICAL TECHNOLOGY CO. LTD., along with their vice president, XIAOQIN DU. The case also implicates three former engineers of Philips' Aurora facility: CHIH-YEE JEN, FINCE TENDIAN, and VLADIMIR NEVTONENKO, who are believed to have taken part in the theft and subsequent misuse of the trade secrets.
A crucial turn in this saga occurred when CHIH-YEE JEN, before leaving Philips, allegedly copied confidential trade secret information from internal company databases without authorization. "Jen stole the proprietary information on behalf of Kunshan GuoLi and Du," outlines the indictment. It is alleged that this information was then used to support the development of competing X-ray tubes. Both Tendian and Nevtonenko are accused of using the stolen data in their work for the newly founded company.
The four individuals charged—Jen, Tendian, Nevtonenko, and Du—face serious legal repercussions if found guilty of the conspiracy. While Jen faces an additional count of possession or attempted possession of stolen trade secrets, his peers, Tendian and Nevtonenko, have joined him in pleading not guilty during their arraignments in federal court. The arraignments for the Chinese companies have not yet been scheduled, and authorities have issued an arrest warrant for Du. The next development is expected by March 31, 2025, with a joint status report due to U.S. District Judge Edmond E. Chang, as the legal process unfolds.
The case is being closely watched by both the medical technology sector and international business observers, highlighting the ongoing tension between trade secret security and corporate espionage. The government's prosecution team, led by Assistant U.S. Attorneys Kavitha Babu, Vikas Didwania, and Ramon Villalpando, is tasked with proving the allegations beyond reasonable doubt, as is mandated by the American legal system. Meanwhile, the public is reminded by officials that "an indictment is not evidence of guilt," and the defendants are "presumed innocent and entitled to a fair trial at which the government has the burden of proving guilt beyond a reasonable doubt."
